Stockscreener 앱 받기
1.16
1.75%
0.02
시장 영업 전:
1.20
0.04
+3.45%
전일 마감가:
$1.14
열려 있는:
$1.14
하루 거래량:
39,034
Relative Volume:
0.23
시가총액:
$72.80M
수익:
$33.79M
순이익/손실:
$-18.67M
주가수익비율:
-3.2384
EPS:
-0.3582
순현금흐름:
$-19.17M
1주 성능:
+16.00%
1개월 성능:
+12.62%
6개월 성능:
-10.77%
1년 성능:
+13.73%
1일 변동 폭
$1.12
$1.16
1주일 범위
$1.01
$1.22
52주 변동 폭
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
명칭
Cytosorbents Corp
전화
973-329-8885
주소
305 COLLEGE ROAD EAST, PRINCETON, NJ
CTSO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.16 | 71.55M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
131.75 | 225.01B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.17 | 154.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.91 | 144.71B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.02 | 117.85B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.26 | 45.90B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2020-09-17 | 개시 | Jefferies | Buy |
| 2020-09-01 | 개시 | SVB Leerink | Outperform |
| 2017-08-08 | 재확인 | Maxim Group | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-05-24 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 재확인 | MLV & Co | Buy |
| 2015-04-01 | 재확인 | MLV & Co | Buy |
| 2015-03-05 | 개시 | MLV & Co | Buy |
| 2015-02-25 | 개시 | WBB Securities | Speculative Buy |
| 2015-01-27 | 재확인 | H.C. Wainwright | Buy |
모두보기
Cytosorbents Corp 주식(CTSO)의 최신 뉴스
Will Cytosorbents Corporation continue its uptrendWeekly Trade Analysis & Reliable Entry Point Alerts - Newser
Why Cytosorbents Corporation stock attracts strong analyst attentionJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
Technical signs of recovery in Cytosorbents CorporationCPI Data & Long-Term Growth Plans - Newser
How sentiment analysis helps forecast Cytosorbents CorporationWeekly Trend Recap & Free Technical Pattern Based Buy Signals - Newser
Sector ETF performance correlation with Cytosorbents CorporationJuly 2025 Drop Watch & Stepwise Trade Execution Plans - Newser
How Efficient Is Cytosorbents Corporation at Controlling Operating CostsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Market reaction to Cytosorbents Corporation’s recent newsExit Point & High Win Rate Trade Alerts - Newser
Volume spikes in Cytosorbents Corporation stock – what they mean2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Is Cytosorbents Corporation reversing from oversold territoryJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
What recovery options are there for Cytosorbents Corporation2025 Geopolitical Influence & Verified Momentum Stock Alerts - Newser
Tools to assess Cytosorbents Corporation’s risk profileTreasury Yields & AI Enhanced Market Trend Forecasts - Newser
Is now a turning point for Cytosorbents CorporationJuly 2025 Setups & Free Accurate Trade Setup Notifications - Newser
How to forecast Cytosorbents Corporation trends using time seriesEarnings Recap Report & Low Drawdown Investment Ideas - Newser
Cytosorbents Corp Q2 2025 Earnings Call Highlights - MSN
Published on: 2025-08-12 20:31:12 - Newser
Is this a good reentry point in Cytosorbents CorporationFree Daily Chart Pattern Stock Forecast - Newser
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2025 Earnings Call Transcript - Insider Monkey
Exit strategy if you’re trapped in Cytosorbents CorporationEquity Market Return Forecast Model Update - Newser
Can volume confirm reversal in Cytosorbents CorporationExit Strategy Guide With Risk Control Plan - Newser
What institutions are buying Cytosorbents Corporation stock now5-Year Price Trend Summary and Analysis - Newser
Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Cytosorbents Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
How Cytosorbents Corporation stock performs during market volatilityTechnical Screener for High Growth Stocks - Newser
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips - Investing.com
CytoSorbents Corp (CTSO) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
CytoSorbents Reports Positive Q2 2025 Financial Results - TipRanks
CTSO: Analyst Jason Kolbert Maintains "Buy" Rating and $10 Price Target | CTSO Stock News - GuruFocus
Cytosorbents Corp reports results for the quarter ended June 30Earnings Summary - TradingView
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Reversal indicators forming on Cytosorbents Corporation stockFree Wealth Building Stock Market Ideas - Newser
What MACD signals say about Cytosorbents CorporationWeekly Market Direction and Sector Summary - Newser
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Cytosorbents Corp (CTSO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.74%
0.24%
자본화:
|
볼륨(24시간):